📰 Exact Science News
Page 2 - Exact Science News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Science. Real-time updates on events, politics, business and more.
March 13, 2024
Cologuard Plus is only noninvasive test to be evaluated head-to-head against an independent fecal immunochemical test, which it significantly outperformed 20,000-participant BLUE-C study included...
March 13, 2024
The new test detected 94% of cancers and was 91% accurate in determining who didn’t have cancer, up from 92% cancer sensitivity and 87% specificity for the original Cologuard.
February 28, 2024
MADISON, Wis.--(BUSINESS WIRE)--Feb 28, 2024--
February 28, 2024
28.02.2024 - Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the launch of the Riskguard hereditary cancer test in the United States. The Riskguard test provides an individualized patient report that includes ... Seite 1
February 28, 2024
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]
February 22, 2024
EXAS earnings call for the period ending December 31, 2023.
February 21, 2024
Exact Sciences Corp (EXAS) Announces 17% Revenue Increase and Provides Optimistic 2024 Outlook
February 16, 2024
Akumin (NASDAQ:AKUMQ – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares Akumin and Exact […]
February 7, 2024
This company hasn't performed well in the past 12 months.
January 22, 2024
These stocks can reward patient investors.